Table 2 Recipient and donor C7 genotype distribution and the association with HCC recurrence
Genotype distribution, n (%) | P value | HWE P value | ||
|---|---|---|---|---|
Recurrence (n = 29) | Non-recurrence (n = 44) | |||
Recipient rs9292795 | ||||
AA | 1(3.4%) | 8(18.2%) | ||
AT | 8(27.6%) | 20(45.5%) | 0.016 | 0.858 |
TT | 20(69.0%) | 16(36.4%) | ||
Recessive model | ||||
AA | 1(3.4%) | 8(18.2) | ||
AT/TT | 28(96.6%) | 36(81.8%) | 0.078 | |
Dominant model | ||||
TT | 20(69.0%) | 16(36.4%) | 0.009 | |
AA/AT | 9(31.0%) | 28(63.6%) | ||
Additive model | ||||
AT | 8(27.6%) | 20(45.5%) | ||
AA/TT | 21 | 24 | 0.146 | |
Donor rs9292795 | ||||
AA | 3 (10.3%) | 4(9.1%) | ||
AT | 16(55.2%) | 23(52.3%) | ||
TT | 10(34.5%) | 17(38.6%) | 0.933 | 0.355 |
Recessive model | ||||
AA | 3(10.3%) | 4(9.1%) | ||
AT/TT | 26(89.7%) | 40(90.9%) | 1.000 | |
Dominant model | ||||
TT | 10(34.5%) | 17(38.6%) | ||
AA/AT | 19(65.5%) | 27(61.4%) | 0.087 | |
Additive model | ||||
AT | 16(55.2%) | 23(52.3%) | ||
AA/TT | 13(44.8%) | 21(47.7%) | 1.000 | |